Effect of Glycerol on Fosfomycin Activity against Escherichia coli

Fosfomycin is an antimicrobial that inhibits the biosynthesis of peptidoglycan by entering the bacteria through two channels (UhpT and GlpT). Glycerol is clinically used as a treatment for elevated intracranial pressure and induces the expression of glpT in Escherichia coli. Glycerol might offer syn...

Full description

Saved in:
Bibliographic Details
Published inAntibiotics (Basel) Vol. 11; no. 11; p. 1612
Main Authors Ortiz-Padilla, Miriam, Portillo-Calderón, Inés, Velázquez-Escudero, Ana, Rodríguez-Baño, Jesús, Pascual, Álvaro, Rodríguez-Martínez, José Manuel, Docobo-Pérez, Fernando
Format Journal Article
LanguageEnglish
Published Basel MDPI AG 12.11.2022
MDPI
Subjects
Antiinfectives and antibacterials
Antimicrobial agents
antimicrobial resistance
Assaying
Biosynthesis
Carbon
Dilution
E coli
Escherichia coli
Fosfomycin
Genes
Glycerol
Intracranial pressure
Kinases
optimization treatment
Peptidoglycans
Subpopulations
Online AccessGet full text

Cover

More Information
Summary:Fosfomycin is an antimicrobial that inhibits the biosynthesis of peptidoglycan by entering the bacteria through two channels (UhpT and GlpT). Glycerol is clinically used as a treatment for elevated intracranial pressure and induces the expression of glpT in Escherichia coli. Glycerol might offer synergistic activity by increasing fosfomycin uptake. The present study evaluates the use of glycerol at physiological concentrations in combination with fosfomycin against a collection of isogenic mutants of fosfomycin-related genes in E. coli strains. Induction of fosfomycin transporters, susceptibility tests, interaction assays, and time-kill assays were performed. Our results support the notion that glycerol allows activation of the GlpT transporter, but this induction is delayed over time and is not homogeneous across the bacterial population, leading to contradictory results regarding the enhancement of fosfomycin activity. The susceptibility assays showed an increase in fosfomycin activity with glycerol in the disk diffusion assay but not in the agar dilution or broth microdilution assays. Similarly, in the time-kill assays, the effect of glycerol was absent by the emergence of fosfomycin-resistant subpopulations. In conclusion, glycerol may not be a good candidate for use as an adjuvant with fosfomycin.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2079-6382
2079-6382
DOI:10.3390/antibiotics11111612